Literature DB >> 27239696

Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.

Callum J Dickson1, Viktor Hornak1, Camilo Velez-Vega1, Daniel J J McKay1, John Reilly2, David A Sandham2, Duncan Shaw2, Robin A Fairhurst3, Steven J Charlton4, David A Sykes4, Robert A Pearlstein1, Jose S Duca1.   

Abstract

Ligand binding to membrane proteins may be significantly influenced by the interaction of ligands with the membrane. In particular, the microscopic ligand concentration within the membrane surface solvation layer may exceed that in bulk solvent, resulting in overestimation of the intrinsic protein-ligand binding contribution to the apparent/measured affinity. Using published binding data for a set of small molecules with the β2 adrenergic receptor, we demonstrate that deconvolution of membrane and protein binding contributions allows for improved structure-activity relationship analysis and structure-based drug design. Molecular dynamics simulations of ligand bound membrane protein complexes were used to validate binding poses, allowing analysis of key interactions and binding site solvation to develop structure-activity relationships of β2 ligand binding. The resulting relationships are consistent with intrinsic binding affinity (corrected for membrane interaction). The successful structure-based design of ligands targeting membrane proteins may require an assessment of membrane affinity to uncouple protein binding from membrane interactions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27239696     DOI: 10.1021/acs.jmedchem.6b00358

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.

Authors:  Donglu Zhang; Cornelis E C A Hop; Gabriela Patilea-Vrana; Gautham Gampa; Herana Kamal Seneviratne; Jashvant D Unadkat; Jane R Kenny; Karthik Nagapudi; Li Di; Lian Zhou; Mark Zak; Matthew R Wright; Namandjé N Bumpus; Richard Zang; Xingrong Liu; Yurong Lai; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

2.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

Review 3.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

Review 4.  Ligand binding at the protein-lipid interface: strategic considerations for drug design.

Authors:  Jian Payandeh; Matthew Volgraf
Journal:  Nat Rev Drug Discov       Date:  2021-07-13       Impact factor: 84.694

5.  Analysis of L-DOPA and droxidopa binding to human β2-adrenergic receptor.

Authors:  Akash Deep Biswas; Andrea Catte; Giordano Mancini; Vincenzo Barone
Journal:  Biophys J       Date:  2021-11-10       Impact factor: 4.033

6.  A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists.

Authors:  Elisia Villemure; Jack A Terrett; Robin Larouche-Gauthier; Martin Déry; Huifen Chen; Rebecca M Reese; Shannon D Shields; Jun Chen; Steven Magnuson; Matthew Volgraf
Journal:  ACS Med Chem Lett       Date:  2021-07-19       Impact factor: 4.632

7.  Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.

Authors:  Peter Obi; Senthil Natesan
Journal:  J Med Chem       Date:  2022-09-06       Impact factor: 8.039

8.  Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions.

Authors:  Agustín Bruzzese; Carles Gil; James A R Dalton; Jesús Giraldo
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

9.  Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting β2-Adrenergic Receptor Agonists.

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2021-08-01       Impact factor: 4.054

Review 10.  Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design.

Authors:  Xiaojing Yuan; Yechun Xu
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.